Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Filter by Categories
2008
2009
2010
Announcements
Articles
Articles and Publications
Campaign
Case Studies
Charge Capture and Pricing
Coding Integrity
Company
Consulting
Craneware Insights Articles
Education
Home
Journey
News & Events
Opportunities
Other
post
Press Releases
Products
Services
Testimonial
Trade Shows
Uncategorized
Uncategorized
Upcoming Events
Value Cycle
Webinars
White Papers

Are the CPT codes for the Janssen (Johnson & Johnson) COVID-19 vaccine now active?

Yes. CMS has updated its COVID-19 Vaccines and Monoclonal Antibodies website to indicate that the applicable Janssen COVID-19 vaccine CPT codes are retroactively effective back to 2/27/2021, the date the vaccine was granted its Emergency Use Authorization (EUA) by the FDA.

It is important to highlight that the CMS COVID-19 Vaccine website instruct providers not to bill for the vaccine product itself, CPT 91303, if the provider receives the vaccine at no cost. In these instances, providers would report the appropriate administration code only, CPT 0031A.

Code CPT Short Descriptor Labeler Name Vaccine/Procedure Name Payment Allowance Effective Dates
91303 SARSCOV2 VAC AD26 .5ML IM Janssen Janssen Covid-19 Vaccine $0.010* 02/27/2021 – TBD
0031A ADM SARSCOV2 VAC AD26 .5ML Janssen Janssen Covid-19 Vaccine Administration $28.390** 02/27/2021 – TBD

As always, we would caution there may be a delay for both MACs and commercial payers to update their respective claims processing systems to accept these new codes. We would advise confirming code availability with your respective payers prior to claim submission.

CMS COVID-19 Vaccines and Monoclonal Antibodies website:
https://www.cms.gov/medicare/medicare-part-b-drug-average-sales-price/covid-19-vaccines-and-monoclonal-antibodies

Skip to toolbar